- Precision diagnostics firm MDxHealth (NASDAQ:MDXH) introduced on Monday preliminary This autumn income of ~$24.7M, representing a year-over-year development of 28%.
- Comparatively, the consensus comes at $22.1M.
- The preliminary full-year 2024 income was $90.0M, vs. $85.3M consensus.
- The corporate expects 2025 income of $108M-110M, up 20%-22% from final 12 months.
- The consensus stands at $102.4M.
- MDxHealth mentioned the 2025 steerage confirms its view of adjusted EBITDA profitability within the first half of this 12 months.